Quantitative assessment of perirenal fat density in renal cell carcinoma: a combined radiologist-driven and YOLO-based CT study.
Source check: Source checked. Not independent scientific confirmation.
Finding / tested result: YOLOv8-based normalized PRFD assessment compared with radiologist manual measurements in 57 RCC cases and 82 controls; upper-pole PRFD differences at left/right (p=.032/.040); model measurements broadly agree with manual assessment depending on attenuation normalization. Article AI statement also discloses QuillBot copyediting, but that is not the claimed result.
Technology: YOLO-derived normalized perirenal-fat measurements support an RCC-associated imaging phenotype; cross-sectional density differences do not establish causation or clinical utility.
Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.
- AI contribution
- YOLO-derived normalized perirenal-fat measurements support an RCC-associated imaging phenotype; cross-sectional density differences do not establish causation or clinical utility.
- Limitation / still unknown
- The reviewed source does not establish prospective benefit, broad external validity, or replication beyond the reported study.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://www.frontiersin.org/journals/radiology/articles/10.3389/fradi.2026.1911034/full
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 22 Nov 2026. Review scope: Primary result-bearing material for the stated method, result and evaluation, with bibliographic version information..
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 2/5 · Validation 3/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.